Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311.

Stephen P AcklandV GebskiNicholas ZdenkowskiA WilsonM GreenS TeesH DhillonG Van HazelJ LeviR J SimesJ F ForbesA S Coatesnull null

Published in: Breast cancer research and treatment (2019)

For women with metastatic breast cancer, disease progression, survival or quality of life were no better with high-dose intensity compared to standard dose EC chemotherapy. Australian Clinical Trials Registry registration number ACTRN12605000478617.

Keyphrases

metastatic breast cancer
clinical trial
high dose
open label
phase ii
locally advanced
high intensity
double blind
study protocol
low dose
phase iii
rectal cancer
randomized controlled trial
squamous cell carcinoma
free survival